Brief: Arca Biopharma Announces Submission Of Percent Patent Application For The Treatment Of Coronavirus Infection And Associated Coagulopathy With Rnapc2
09/08/2021 14:00
Aug 9 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA ANNOUNCES SUBMISSION OF PERCENT PATENT
APPLICATION FOR THE TREATMENT OF CORONAVIRUS INFECTION AND
ASSOCIATED COAGULOPATHY WITH RNAPC2
* ARCA BIOPHARMA INC - PLANS TO PURSUE RELATED PATENT
PROTECTION
IN FOREIGN JURISDICTIONS AS APPROPRIATE
Source text for Eikon: ID:nGNX1wh9Kd
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary